Macrophages and Pulmonary Fibrosis
Shengjun Chen1, Xiaodong Song2, Changjun Lv1
1Department of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou 256603, China.
Abstract:
Most chronic respiratory diseases often lead to the clinical manifestation of pulmonary fibrosis. Inflammation and immune disorders are widely recognized as primary contributors to the onset of pulmonary fibrosis. Given that macrophages are predominantly responsible for inflammation and immune disorders, in this review, we first focused on the role of different subpopulations of macrophages in the lung and discussed the crosstalk between macrophages and other immune cells, such as neutrophils, regulatory T cells, NKT cells, and B lymphocytes during pulmonary fibrogenesis. Subsequently, we analyzed the interaction between macrophages and fibroblasts as a possible new research direction. Finally, we proposed that exosomes, which function as a means of communication between macrophages and target cells to maintain cellular homeostasis, are a strategy for targeting lung drugs in the future. By comprehending the mechanisms underlying the interplay between macrophages and other lung cells, we aim to enhance our understanding of pulmonary fibrosis, leading to improved diagnostics, preventative measures, and the potential development of macrophage-based therapeutics.
Insights
Macrophages play a key role in pulmonary fibrosis by interacting with other lung cells. Understanding these macrophage-driven immune responses could lead to new therapies for lung diseases.
Area of Science:
- Immunology
- Pulmonary Medicine
- Cell Biology
Background:
- Chronic respiratory diseases frequently result in pulmonary fibrosis.
- Inflammation and immune dysregulation are key drivers of pulmonary fibrosis.
- Macrophages are central to these inflammatory and immune processes in the lung.
Purpose of the Study:
- To review the role of lung macrophage subpopulations in pulmonary fibrosis.
- To explore macrophage interactions with other immune cells and fibroblasts.
- To investigate exosomes as a therapeutic strategy for pulmonary fibrosis.
Main Methods:
- Literature review focusing on macrophage biology in pulmonary fibrosis.
- Analysis of intercellular communication networks involving macrophages.
- Discussion of potential therapeutic applications of exosomes.
Main Results:
- Macrophages interact extensively with neutrophils, T cells, B cells, and fibroblasts during fibrogenesis.
- Macrophage-derived exosomes represent a novel communication pathway.
- Exosomes offer potential for targeted drug delivery in lung diseases.
Conclusions:
- Understanding macrophage-centric mechanisms is crucial for advancing pulmonary fibrosis research.
- Targeting macrophage-fibroblast interactions and exosome signaling may yield new therapeutic avenues.
- Developing macrophage-based therapeutics holds promise for improved diagnostics and treatment of pulmonary fibrosis.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...


